Endocrine Pharmacotherapy
Coordinated by CPE committee
Speakers:
Dr. Issam Samir, Clinical Pharmacist, Tawam Hospital
Dr. Hadaya Gharibyar, Poison and Drug Information Officer, Health Authority – Abu Dhabi
Dr. Maha Al Hakim, Drug Information Specialist, Pharmacist in charge‐discharge planning
service, Pharmacist in charge of narcotic and control drugs, Mafraq Hospital
Dr. Yousef Hassan, MD, FACE, Consultant Endocrinologist, Mafraq Hospital
Dr. Mohamed El Shishtawi, Hospital Pharmacist, Al Rahba Hospital
Target Audience: Pharmacist Practitioners
Date & Time: Saturday, March 27th, 2010 – 2:00 PM to 9:30 PM
First Session Registration begins: 1:30 PM & ends: 2:00 PM
Second Session Registration begins: 5:30 PM & ends: 6:00 PM
Venue: Health Authority Auditorium, Abu Dhabi
Accredited by Health Authority – Abu Dhabi
- For first session 3.5 CPE hrs
-
- For second session 3.5 CPE hrs
Learning Objectives
Upon completion of this educational activity, participants should be able to:
1. Identify the pathophysiology of diabetes
2. Recognize the different insulin regimens
3. Discuss AACE/ACE recommendations in the management of type 2 diabetes
4. Describe key points for enhancing the interaction with patients
5. Describe common diabetes medication misunderstandings shared by patients
6. Identify major risk factors of osteoporosis and who requires BMD testing
7. Recognize the different types of medications used in treatment and management of osteoporosis
8. Demonstrate the basic Pharmacological principles of thyroid disease medicines
9. Optimize the outcomes of thyroid disease pharmacological management
10. Identify the clinical picture of Cushing Syndrome, diagnose Cushing Syndrome and discuss treatment
Presents a Symposium on
CME/CPD Section - HAAD
Program
Date
From
To
Speaker
Endocrine Pharmacotherapy
Osteoporosis
27 March, 2010
2:00 pm
3